A health care monitoring system that uses ontology agents
Ημερομηνία
2016Γλώσσα
en
Λέξη-κλειδί
Επιτομή
The healthcare domain is mission critical and vast research efforts keep being funded in order to improve life quality of people. Health management consists of specific cooperation intensive activities, while medical knowledge and systems are spatially and functionally distributed. Also, medical data flows are inefficient for dynamic data delivery to stakeholders while the manifold of medical care derives from their diversity and autonomy. In such an environment we propose the implementation of vhMentor based on a solid ontological schema. The aim of the proposed system is to suggest an agent-based solution to overcome the automation deficiencies of medical data monitoring. Towards this objective we study the applicability and usefulness of the mobile agent technology in the healthcare domain. Furthermore, we implemented the encapsulation of remote sensing and medical devices signals in an ontology-supported healthcare information system. The resulting system encourages the future implementation of next generation services (e.g. decision making and reasoning) through autonomous - intelligent agents and reasoning engines. © 2016 IEEE.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Drug-induced endocrinopathies and diabetes: A combo-endocrinology overview
Diamanti-Kandarakis E., Duntas L., Kanakis G.A., Kandaraki E., Karavitaki N., Kassi E., Livadas S., Mastorakos G., Migdalis I., Miras A.D., Nader S., Papalou O., Poladian R., Popovic V., Rachoń D., Tigas S., Tsigos C., Tsilchorozidou T., Tzotzas T., Bargiota A., Pfeifer M., on behalf of COMBO ENDO TEAM: 2018 (2019)In the currently overwhelming era of polypharmacy, the balance of the dynamic and delicate endocrine system can easily be disturbed by interfering pharmaceutical agents like medications. Drugs can cause endocrine abnormalities ... -
Host – virus – drug interactions as determinants of COVID-19’s phenotypes: A data-driven hypothesis
Vavougios G.D. (2020)There is a growing body of evidence on the significance of interactions between comorbidities, their treatments and COVID-19 clinical phenotypes. The hypothesis explored herein is that pharmaceutical compounds currently ... -
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort
Panopoulos S., Chatzidionysiou K., Tektonidou M.G., Bournia V.K., Drosos A.A., Liossis S.-N.C., Dimitroulas T., Sakkas L., Boumpas D., Voulgari P.V., Daoussis D., Thomas K., Georgiopoulos G., Vosvotekas G., Garyfallos A., Sidiropoulos P., Bertsias G., Vassilopoulos D., Sfikakis P.P. (2020)Background: European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc's optimal management. Herein, we describe current treatment modalities and drug survival ...